摘要
In a recent publication in Nature,Ising et al.reported the effect of the NLRP3 inflammasome on Aβ-induced tau pathology in Alzheimer’s disease(AD).The findings indicate that NLRP3 may be a novel target for the treatment of AD.
基金
funded by the National Natural Science Foundation of China(NSFC)(91749116 and 81622015).W.S.is the holder of the Tier 1 Canada Research Chair in Alzheimer’s Disease.Y.Z.was awarded by the Michael Smith Foundation for Health Research(MSFHR).
